In the past, money was no object when cancer specialists considered which drugs would provide the best treatment for their patients. But some top oncologists are rethinking that stance.
Drug costs become bigger issue in cancer care
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.